Clinical trial · Interventional
Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's Lymphoma
NCT01761500CI-TRIAL-00008781completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Non-Hodgkin's lymphoma is an aggressive malignance disease in children and adolescents. This study was designed to evaluate the efficacy and toxicity of the modified NHL-BFM-90 protocol in Chinese children and adolescents with Non-Hodgkin's lymphoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood Non-Hodgkin's Lymphoma | Childhood Non-Hodgkin Lymphoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Modified BFM-90 protocol | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Modified BFM-90 protocol
- description
- Using the Modified BFM-90 protocol to treat Chinese children and adolescents with NHL
- interventionNames
- Other: Modified BFM-90 protocol
Primary outcomes (1)
- measure
- The event free survival (EFS)
- timeFrame
- Up to 5 years
- description
- The event free survival (EFS) was defined as the time from the start of treatment to one of the following events: death from any cause, disease progression during treatment, relapse, or to the date of the last follow up if patient did not experience any event.
Secondary outcomes (1)
- measure
- Number of Participants with Adverse Events
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Months
- Maximum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: 1. Untreated children and adolescents with Non-Hodgkin's lymphoma 2. Age ≤ 20 years 3. The informed consent of their guardians was obtained. Exclusion Criteria: 1. Recurrence Non-Hodgkin's lymphoma 2. Age \>20 years 3. No abide by the protocol
References
Publications (0)
Data not yet available
No reference posted for this study.